All articles tagged with #thyroid cancer
Former Attorney General Pam Bondi says she is undergoing treatment for thyroid cancer after a recent diagnosis following her departure from the Justice Department; she had surgery a few weeks ago, was fired by Trump in April, and has been tapped for an AI policy advisory panel. She is also set to testify before the House Oversight Committee about the Epstein files as a DOJ watchdog plans an audit of their release.
President Donald Trump has named former Attorney General Pam Bondi to the President’s Council of Advisors on Science and Technology (PCAST) as a liaison to the White House on AI policy, a consolation prize after Bondi was fired over her handling of the Epstein files. Bondi, 60, was diagnosed with thyroid cancer weeks after leaving the DOJ, and Todd Blanche has been serving as acting attorney general. Bondi’s appointment places her among top tech figures advising the White House on science and technology policy.
Pam Bondi, the former U.S. attorney general, has been diagnosed with thyroid cancer shortly after leaving the DOJ and is recovering after treatment. Details remain sparse and Bondi has not publicly commented. The disclosure follows her appointment to the President’s Council of Advisors on Science and Technology and comes amid other health news affecting the Trump administration.
Former Attorney General Pam Bondi disclosed a thyroid cancer diagnosis and is undergoing treatment, including recent surgery, saying she is recovering well; she is slated to testify Friday in the House Oversight Committee’s Epstein probe and has been reported to join the Presidential Council of Advisors on Science and Technology.
Former US Attorney General Pam Bondi, ousted from her role last month, has been diagnosed with thyroid cancer and is undergoing treatment, including surgery. She will join the White House's AI advisory council (PCAST) and is slated to testify about the Epstein files before the House Oversight Committee.
Former Attorney General Pam Bondi revealed she has thyroid cancer and is undergoing treatment, including surgery a few weeks ago, and is recovering well. She left the DOJ after being fired by President Trump in April, with Todd Blanche serving as acting attorney general. Bondi is slated to testify Friday in the House Oversight Committee’s Epstein probe, and Axios reported she will join the administration’s Presidential Council of Advisors on Science and Technology.
A Lund University study of more than 1.1 million men who fathered children found that those with severely reduced fertility had almost twice the risk of colorectal cancer and about three times the risk of thyroid cancer compared with men who conceived naturally, suggesting a genetic link between fertility issues and cancer risk amid rising male infertility.
A UK mom’s fatigue, hair loss, heart palpitations, trouble swallowing, and neck lumps were repeatedly dismissed by doctors as a result of being a busy mother. After six visits with little help, she privately funded scans that showed suspicious thyroid nodules and enlarged lymph nodes. An initial biopsy came back non-cancerous, and she waited months for a follow-up. A second private scan in December 2025 revealed progression, leading to ultrasound and ENT evaluation; a biopsy confirmed thyroid cancer, and she subsequently had her thyroid removed and is awaiting pathology to determine staging and the next steps, likely including iodine therapy or radiation. She urges others to trust their gut and push for answers when something feels wrong.
Thyroid cancer is more common in women (often in their 40s–50s). The number-one sign is a new neck mass, typically painless; while most neck lumps are benign, about 5% are cancerous. Early detection improves outcomes, so see a doctor if you notice a lump.
Researchers at the Clayman Thyroid Center reviewed clinical trials, adverse reports, and real-world data and found little to no evidence that GLP-1 receptor agonists (including Ozempic, Wegovy, and Mounjaro) raise the risk of thyroid cancer, including medullary thyroid cancer. Any uptick in diagnoses is likely due to detection bias from more frequent screening. While large population studies would help solidify certainty, current guidance aligns with avoiding GLP-1s only for people with personal or family histories of medullary thyroid cancer or MEN2.
A man with rare stage 4 thyroid cancer experienced a miraculous recovery after receiving an experimental off-label immunotherapy drug, tarlatamab, which is typically used for lung cancer. His case highlights the potential of repurposing existing drugs for rare cancers, though further research is needed to understand the risks and optimal use of such treatments.
Brian Schottenheimer, NFL coach, shared his personal experience with thyroid cancer at age 28, including the surgery to remove lymph nodes, and expressed gratitude for the support he received, highlighting the importance of hope and resilience in facing serious health challenges.
Brian Schottenheimer, Cowboys head coach, revealed he was diagnosed with thyroid cancer at age 28 and successfully overcame it, emphasizing the importance of hope and support during such battles, inspired by fellow cancer survivor and NFL figure Dan Snyder.
Concerns are rising over potential cancer links, especially thyroid cancer, associated with weight loss drugs like Ozempic and Mounjaro, which are GLP-1 receptor agonists. While these drugs aid weight loss and improve metabolic health, their long-term safety remains uncertain, with limited evidence suggesting possible risks. They are not recommended for individuals with a history of thyroid cancer or certain genetic conditions, and more research is needed to fully understand their safety profile.
Shari Redstone, chair of Paramount Global, revealed she was diagnosed with thyroid cancer earlier this year and underwent surgery in May, with ongoing treatment. Despite her health challenges, she continues her professional and philanthropic activities. Her diagnosis adds complexity to her ongoing efforts to merge Paramount with Skydance Media, a deal still awaiting regulatory approval, and her health situation may lead to her stepping down from the merged company's board.